From the magazine LSR 2/2020 | S. 100-106 The following page is 100

Competition Law Limits for Pharmaceutical Patent Settlements

ECJ, C-307/18 of January 30, 2020 (Paroxetine) on Pay-for-Delay

Pay-for-delay, Patent Law, Competition Law

I. Background

In the pharmaceutical sector, patent disputes between an originator as patentee and a generic as alleged infringer are occasionally settled in the following basic form: the originator transfers value, e.g. in form of a payment, to the generic, and the generic commits to temporarily refrain from market entry (non-commercialization) and patent challenge (nochallenge). These so-called pay-for…

Melden Sie sich für den LSR-Newsletter an und bleiben Sie informiert.